Skip to Main Content

News Center

Biomarkers

CERSI Symposium Highlights Use of Biomarkers in Drug Development

August 28, 2015

More than 500 researchers from academia, government, and industry gather to gain perspective on biomarker development and the application of biomarkers in preclinical and clinical research.

SOP’s Kane to Test New Biomarkers of Fetal Alcohol Spectrum Disorders

September 10, 2014

Collaboration with University of New Mexico College of Pharmacy will employ expertise of the School’s Mass Spectrometry Center.

CERSI Conference Spotlights Need for Mass Spectrometry in Drug Development

April 16, 2014

Researchers from academia, government, and industry examine current challenges surrounding mass spectrometry as a drug development tool, including its status of adoption by industry and potential regulatory implications.

SOP Joins International Group to Advance Treatments for Radiation Injuries

January 31, 2013

The Mass Spectrometry facility at the University of Maryland School of Pharmacy will lead investigation to identify and characterize new biomarkers of radiation damage.

Ellis S. Grollman Lecture Brings Leaders in Pharmaceutical Sciences to SOP

November 15, 2012

Leslie Benet, PhD, professor and former chair of the Department of Bioengineering and Therapeutic Sciences at the University of California, San Francisco (UCSF), delivers keynote address.